We have examined elongation by RNA polymerase II initiated at a promoter and have identified two classes of elongation complexes. Following initiation at a promoter, all polymerase molecules enter an abortive mode of elongation. Abortive elongation is characterized by the rapid generation of short transcripts due to pausing of the polymerase followed by termination of transcription. Termination of the early elongation complexes can be suppressed by the addition of 250 mM KCI or 1 mg of heparin per ml soon after initiation. Elongation complexes of the second class carry out productive elongation in which long transcripts can be synthesized. Productive elongation complexes are derived from early paused elongation complexes by the action of a factor which we call P-TEF (positive transcription elongation factor). P-TEF is inhibited by 5,6-dichloro-1-B-Dribofuranosylbenzimidazole at concentrations which have no effect on the initiation of transcription. By using templates immobilized on paramagnetic particles, we show that isolated preinitiation complexes lack P-TEF and give rise to transcription complexes which can carry out only abortive elongation. The ability to carry out productive elongation can be restored to isolated transcription complexes by the addition of P-TEF after initiation. A model is presented which describes the role of elongation factors in the formation and maintenance of elongation complexes. The model is consistent with the available in vivo data concerning control of elongation and is used to predict the outcome of other potential in vitro and in vivo experiments.It is now clear that the transcription of eucaryotic genes is controlled during the elongation phase as well as at initiation. The number of genes for which elongational control has been implicated is growing (80). The three proto-oncogenes c-myc (52, 61, 65, 79, 85), c-myb (4, 62), and c-fos (16, 70) have been shown to be controlled at elongation. Adenovirus (37,66,73), simian virus 40 (36, 67), minute virus of mice (39), and human immunodeficiency virus (HIV) (40,41,75,83) have been demonstrated to have specific blocks to transcription elongation. The mRNA levels for the adenosine deaminase genes of humans and mice are at least partly controlled by a regulated block to elongation (13,14,42,48,58). Many genes in Drosophila melanogaster have RNA polymerase II molecules arrested early after initiation (68,69). While control of elongation has been implicated in these examples, very little is known about the molecular mechanisms involved.A number of factors that influence elongation and termination by procaryotic RNA polymerase have been defined (86). In particular, the N and Q protein-mediated antitermination systems of lambda and similar bacteriophages provide a model for how specific gene expression can be controlled by modifying RNA polymerase elongation. The mechanism by which lambda Q protein functions has been partially elucidated (87). A key feature in this process is the pausing of the RNA polymerase downstream of the initiation...